|Bid||62.41 x 3000|
|Ask||63.44 x 1100|
|Day's Range||62.38 - 63.94|
|52 Week Range||59.07 - 86.31|
|Beta (3Y Monthly)||0.82|
|PE Ratio (TTM)||11.48|
|Earnings Date||Apr 2, 2019|
|Forward Dividend & Yield||1.76 (2.77%)|
|1y Target Est||74.09|
Holmes, now 35, and Theranos’s former chief operating officer, Ramesh “Sunny” Balwani, have a pending criminal fraud case against them in a federal court in the heart of Silicon Valley.
Lululemon (LULU) shares popped over 3% Thursday heading into the release of its fourth quarter financial results, as part of its larger 2019 climb. The yoga apparel and athleisure giant's bottom-line looks set to surge as it expands its menswear business, its global reach, and more.
Rite Aid shareholders have approved the company's reverse stock split, the company announced Thursday, a move aimed at keeping the drugstore chain's shares trading on New York Stock Exchange.
The healthcare retail industry is dominated by two companies: CVS Health Corp. CVS has an attractive 3.5% yield, while Walgreens has a lower yield, but a phenomenal track record of dividend growth. Walgreens is a Dividend Aristocrat, having increased its dividend for over 40 years in a row.
Walgreens Boots Alliance (WBA) closed at $62.79 in the latest trading session, marking a -1.54% move from the prior day.
Not a day goes by that healthcare costs aren't being discussed across each corner of media. With the 2020 election now underway, politicos are ratcheting up the rhetoric over healthcare costs and the political ads are already spinning the topic. And all of this is for good reason. Healthcare costs in the U.S. are high and rapidly rising, especially if you're of retirement age. According to the U.S. Centers for Medicare and Medicaid Services (CMS) -- healthcare spending increased in 2017 by 3.90% to $3.9 trillion or $10,739 per person. This represents 17.90% of the then gross domestic product of the U.S. (GDP). In fact, in a recently published book, More than Medicine: The Broken Promise of American Health by Bob Kaplan, he argues that the U.S. pays way more than its mature economic peers.For example, the U.S. pays 18% of its gross domestic product (GDP) on healthcare whereas the European Union (E.U.) only pays 10% of its combined GDP. And, to make it worse, the U.S. has a lower life expectancy than many nations around the globe. Add in a high poverty rate, which can lead to further health challenges for young and old and other factors showing health troubles, including infant mortality, and the nation doesn't look too healthy. American healthcare may well get even more expensive, as the U.S. ages and becomes less healthy by the day. This isn't a good mix for one of the leading economies of the planet.In a recent study by the U.S. Department of Commerce and the U.S. Census, by 2035, it is projected that 78 million folks will be 65 years or older. That same year, those at or under the age of 18 years will number just 76 million. America is becoming a nation of the elderly -- a significant change in the demographics of a nation traditionally known for its healthy and able folks. It's a shift that leaves many wondering where our economic productivity gains will come from. And, as we know, the elderly population requires the most attentive healthcare … no wonder healthcare spending is climbing.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks on the Rise Heading Into the Second Quarter While this sounds bleak, there is a silver lining here for us as investors. And no, I'm not suggesting that we look at gym companies (although I am poking around at that market with some innovations that I'll be writing about in Profitable Investing in the near future). Rather, I'm suggesting that investing in healthcare stocks that pay dividends is a smart source for capital gains … WP Carey Click to Enlarge Source: Bloomberg One healthcare stock, in particular, comes to mind … I'm referring to WP Carey (NYSE:WPC), which I've written about extensively for InvestorPlace.WP Carey is a REIT, which since coming to the public market, has generated a return of 1,348.28% for an average annual equivalent return of 13.46%. That's not too shabby any way you cut it. The business itself is a curious one: WP Carey doesn't operate its properties, and it doesn't pay for maintenance, insurance, or taxes. Instead, it executes "triple net leases." This means that it locks up long-term cashflows with less risk in rising costs for the properties and the vagrancies of tax rates.Its tenants pay for all of that, thus WP Carey profits from other peoples' money.In the healthcare market, there is a specific equivalent in the following security. Well, this next security is technically a real estate investment trust (REIT) that owns and acquires healthcare facilities including inpatient and outpatient facilities as well as surgical centers and specialty healthcare facilities. Their properties amount to more than 120 properties in 25 states as well as some newer innovative investments in Germany. Scroll down to discover what it is … Medical Properties Trust (MPW) Click to Enlarge Source: Bloomberg Medical Properties Trust (NYSE:MPW) has properties that are leased on a net basis to operators that run the facilities and pay rent month after month for years. The portfolio has expanded dramatically over the recent year with only a small pause in the past year. But it continues to look to expand its portfolio with the right properties in an ever-expanding market.Revenues are climbing with gains running at over 11.30% in just the trailing year. And the funds from operations (FFO) which measures just the return rate from the cashflows from the property portfolio is ample at 11.60%, which is impressive for the REIT space. This contributes to an impressive return on its assets at 11.40% and is what delivers for shareholders with a return on equity of 24.30%.And the stock continues to reflect its performance as a company. Over the past ten years, the stock has delivered a total return of 994.12% for an average annual equivalent of 26.79%. It is a disciplined company when it comes to debt and leverage as its debt to capital is at only 47.00%. This provides the ability to easily service its current debts and provides eased access for credit to fund additional acquisitions. Valued at only 1.49 times its book value, MPW is a steal from a price-book (P/B) perspective. This ratio has climbed significantly over the trailing year, from 1.14 times back in October 2018.But it isn't just the P/B ratio that's rising, but the actual value of the assets. Over the past five years alone, the underlying book value per share has gone from $7.98 to a current $12.27, which represents an impressive gain of 53.76%. This is important as it shows genuine growth in the underlying company and not just the stock price. The dividend is currently at 25 cents per share and has been climbing in distribution by an average annual rate of 4.30% over the past five years. This equates to a current yield of 5.48%. * Top 7 Service Sector Stocks That Will Pay You to Own Them Medical Properties Trust makes for a great buy in the healthcare market (which should be purchased in a taxable account). This is due to the Tax Cuts and Jobs Act (TCJA) which provides a tax deduction of 20% of the dividend distribution for U.S. individual investors making the taxable equivalent yield even higher. Other Stocks to Play HealthcareInside the Profitable Investing model portfolios, I have the overall market for healthcare synthetically invested in the Vanguard Healthcare ETF (NYSEARCA:VHT), which remains a buy in a tax-free account. Then, in my Incredible Dividend Machine portfolio inside Profitable Investing, I have three more plays on healthcare …I have the drugmaker Merck (NYSE:MRK), which continues to perform for shareholders. And I have another drugmaker in Pfizer (NYSE:PFE), which follows the success of Merck. Further, I also have Ventas (NYSE:VTR), which as a real estate investment trust (REIT) that owns a series of senior healthcare and related housing care facilities. VTR is doing quite well with the general REIT sector as we move further into 2019.One of the smartest investment lessons that I learned, from one of my best stocks within Profitable Investing, is to capitalize when the opportunity arises. That is, take risks while you lock in revenues! And the aforementioned stocks should continue to position themselves into the thick of the rising healthcare spending market while paying out an ample and rising dividend.Neil George is the editor of Profitable Investing and does not have any holdings in the securities mentioned above. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Invincible Stocks Leading The Bull Market Higher * 5 Dow Jones Stocks Coming to Life * 7 of the Best High-Yield Funds for 2019 and Beyond Compare Brokers The post Invest in America's Rising Healthcare Costs With These Stocks appeared first on InvestorPlace.
Walgreens Boots Alliance (WBA) was on a nice run when we bought in back in October. But that all changed in December, observes Brit Ryle, blue chip specialist and editor of The Wealth Advisory.
Walgreens Boots Alliance Inc NASDAQ/NGS:WBAView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for WBA with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding WBA are favorable, with net inflows of $16.02 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Moody's Investors Service ("Moody's") today placed the ratings of HC Group Holdings III, Inc.(dba Option Care), including the B3 Corporate Family Rating (CFR), under review for upgrade. This follows the announcement that Option Care will merge with BioScrip, Inc. (BioScrip). BioScrip will issue common stock to Option Care in an all-stock deal.
Amazon (AMZN) rolls out payment options via HSA and FSA for medical purchases made on its online platform which is likely to strengthen its healthcare market presence.
Let's see what to expect from FedEx's Q3 fiscal 2019 financial results, which are due out Tuesday, with larger global market conditions possibly trending in the wrong direction for the shipping and logistics powerhouse.
agreed to buy rival Option Care Enterprises, creating one of the largest independent home-therapy companies in the U.S. On completion of the all-stock deal, MDP funds and WBA will own roughly 80% of the combined publicly traded company on a fully diluted basis, with current BioScrip shareholders holding the remainder, the companies said. Option Care CEO John Rademacher will lead the combined company.
Shares of BioScrip Inc. soared 32% toward a 4-year high in premarket trade Friday, after the company announced a deal to merge with privately held Option Care Enterprises Inc., a provider of home and alternate treatment site infusion therapy services owned by funds affiliated with Walgreens Boots Alliance Inc. and private-equity firm Madison Dearborn Partners LLC (MDP). BioScrip's stock is halted for news until 7:30 a.m. Eastern. Under terms of the agreement, BioScrip will issue new shares to Option Care's shareholder and Walgreens and MDP will own about 80% of the combined publicly traded company. BioScrip's market capitalization was about $446.9 million as of Thursday's close. "This is a compelling and complementary fit of two leading players in the U.S. infusion market," said BioScrip Chief Executive Daniel Greenleaf. "Together, we will be able to provide a diverse set of life-improving and cost-effective services to more patients across the United States." BioScrip's stock has rallied 31% over the past 12 months, while the SPDR Health Care Select Sector ETF has gained 6.9% and the Dow Jones Industrial Average has tacked on 3.4%.
DENVER and BANNOCKBURN, Ill., March 15, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (BIOS) (“BioScrip”) and Option Care Enterprises, Inc. (“Option Care”), the nation’s largest independent providers of home and alternate treatment site infusion therapy services, today announced that they have entered into a definitive merger agreement. The combination is expected to create a leading independent provider with the national reach, comprehensive therapy offering and financial capacity to succeed in the attractive and growing home and alternate site infusion services segment of the $100 billion U.S. infusion market.
Walgreens Boots Alliance, Inc. (WBA) today named Heather Dixon as its new senior vice president, global controller and chief accounting officer, effective March 18, 2019. Dixon will join Walgreens Boots Alliance from Aetna, where she was vice president - controller and chief accounting officer since 2017, and previously, assistant controller, from 2016.
Health care is a persistent crisis point for Americans, with the population living longer yet experiencing higher rates of chronic disease than past generations. As a result, we need to find a way to meet those needs at a population level. A growing community of health care startups, along with established companies, are introducing innovative solutions that aim to meet patients where they live.
Amazon (AMZN) shares have climbed roughly 13% to start the year, which tops the market's comeback, but falls way behind fellow FAANG giants Facebook (FB) and Netflix (NFLX). Therefore, Amazon stock still rests over 17% below its 52-week high.
Shares of CVS Health (CVS) surged over 4% through mid-afternoon trading Wednesday on the back of a bullish call from Bernstein analysts. The drugstore chain is also coming off a stronger-than-expected fourth quarter. So, is now the time to buy CVS stock?
There are cheap stocks and then there are stocks that are cheaply priced. In the case of Walgreens Boots Alliance (NASDAQ:WBA), WBA stock is cheaply priced and the company is loaded with impressive, hard-to-replicate assets in markets with promise that are just hitting their stride.Walgreens stock went from a recent high last year of $85.69 in December to its current discounted price around $61 per share. But it has a pedigree of delivering to shareholders, and that cannot be ignored.For over the trailing ten years, WBA stock has returned 214.79% for an average annual equivalent return of 12.15%.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSource: Bloomberg Pay More Attention to WBA StockWalgreens has over 13,000 pharmaceutical and retail stores in 11 countries and remains one of the dominant pharmacies in the U.S. and Britain. This is a good market segment to be in. Drug spending continues to be buoyant, with growth in the U.S. alone on an annual upward march. * 10 Dividend Stock Winners And while Britain has its challenges, with concerns over Brexit, U.S. retail pharma sales make up 75% of the company's revenues.Sales overall for the company are up by 11.30% for the trailing year. And in a market where margins can get pretty thin, WBA maintains an operating margin that is running at an annual rate of 4.70%. This, in turn, is driving very impressive returns for the company. The return on shareholders' equity is at 20.70% and the return on assets is running at 7.80%. The company also delivers a solid return on capital of 14.10%.It does this with very modest leverage. Its cash continues to be ample with continuing flows from rising retail sales. And it has minimal debt, with a debt-to-assets ratio sitting at only 21.10%.Walgreens stock pays a nice dividend that continues to be above the average of the S&P 500 Index, at 2.90%. The current distribution is running at 44 cents a share and it has been rising on average over the past five years by 7.11% a year.All of these positives mean little to the recent market, though -- WBA stock is valued at over a 60% discount to the trailing sales. And again, note that sales have been continuing to rise, making it even more of a bargain.Price-to-book is at 2.25X, which is modest in the current market. And that underlying book value in Walgreens stock continues to climb from recent lows in 2017 to a current $27.14 per share.Source: Bloomberg Bottom Line on Walgreens StockWBA stock is a bargain.And management seems to notice this. Share buying by insiders was on a tear throughout 2018, with buys topping out at over $85 million into December 2018.But what's holding back the outside stock buyers? * 10 Tech Stocks to Buy Now for 2025 First, the presence of Amazon (NASDAQ:AMZN). This company, through its acquisition of an online pharmaceutical subscription company, is building its capabilities to reach consumers directly. And that's competition. But WBA is so ubiquitous in its availability and ease of delivery that it is more of a threat to Amazon's developing market for now than Amazon is to its business.Then there is the concern over the costs and efficiency of brick and mortar retail, which is also part of the Walgreen's business. Again, Walgreens continues to provide an expansive localized outlet for convenience for consumers beyond just prescription drugs. And there is the move already underway by management to review every store location in its vast network for the greatest returns for shareholders.While Walgreens might be slipping back in the pack of the stock market of recent, there's a lot behind this stock to value as it may well make for a good bet for dividends and a win for growth.Neil George is the editor of Profitable Investing and does not have any holdings in the securities mentioned above. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 of the Best Stocks to Buy Under $10 * 7 Retail Stocks Winning in 2019 and Beyond * The 10 Best Stocks to Buy for the Bull Market's Anniversary Compare Brokers The post It's Time to Pay More Attention to Walgreens Stock appeared first on InvestorPlace.
Rite Aid (RAD) announces leadership transition and organizational revamping in a bid to better align its operations and minimize costs.